Search for Clinical Trial Results

Sponsored By

Cystadenocarcinoma, Serous - 24 Studies Found

Status Study
Recruiting Study Name: A Phase II Evaluation of Afatinibin Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma
Condition: HER2/Neu+ Uterine Serous Carcinoma
Date: 2015-07-02
Interventions: Drug: Afatinib Afatinib, 40 mg orally once daily on a 21 day cycle for the first 12 weeks, then every 28
Not yet recruiting Study Name: Proof-of-concept Study of Birinapant in Combination With Platinum Based Chemotherapy in Subjects With High Grade Serous Carcinomas
Condition: Advanced Newly Diagnosed or Recurrent High Grade Serous Carcinomas (HGSC)
Date: 2016-04-22
Interventions:
  • Drug: Birinapant Birinapant -

Completed Study Name: Papillary Serous Carcinoma of the Endometrium
Condition: Endometrial Cancer
Date: 2007-08-09
Interventions:
  • Drug: Paclitaxel 50 mg/m^2 IV

Completed Study Name: A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma
Condition: Uterine Cancer
Date: 2005-10-03
Interventions:
  • Drug: Carboplatin and Paclitaxel and Pelvic Radiation Therapy

Completed Study Name: Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma
Condition: Uterine Cancer
Date: 2007-07-23
Interventions:
  • Drug: Imatinib Mesylate

Active, not recruiting Study Name: Selumetinib in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer
Condition:
  • Borderline Ovarian Surface Epithelial-stromal Tumor
  • Ovarian Serous Cys
    Date: 2007-10-22
    Interventions:
    • Drug: selumetinib Given PO
Not yet recruiting Study Name: Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer
Condition:
  • Endometrial Serous Adenocarcinoma
  • Stage I Uterine Corpus Cancer
    Date: 2011-04-28
    Interventions:
    • Other: Diagnostic Laboratory Biomarker Analysis

Not yet recruiting Study Name: Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer
Condition:
  • Endometrial Serous Adenocarcinoma
  • Stage IIIA Uterine Corpus Can
    Date: 2014-04-10
    Interventions:
    • Drug: Paclitaxel Given IV
Recruiting Study Name: To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers
Condition:
  • Pancreatic Adenocarcinoma Metastatic
  • Ovarian Serous Adenocarcinoma Date: 2014-07-01
    Interventions: Drug: Plerixafor A continuous 7 day intravenous infusion, starting at a dose of 20 ug/kg/hr, and subsequ
Completed Study Name: Phase II ABT-888 With Cyclophosphamide
Condition:
  • Ovarian Cancer
  • Primary Peritoneal Cancer
  • Drug: ABT-888 PARP enzymes are
Next >>>